CaNCURE Co-op Showcase

dsc_9827dsc_9836-1The CaNCURE Team would like to send out a congratulations to the 8 trainees who completed their CaNCURE co-op this December! We were so proud to see all your accomplishments at our second annual CaNCURE Co-op Showcase and to learn that for many of you, this co-op was a career-defining experience!

 

 


 

Upcoming Events

Check back soon for new events


Mentor Spotlight


Ciprian Catana, M.D., Ph.D.

Associate Professor in Radiology , HMS

Our laboratory seeks to improve the quantification of the PET data using the simultaneously acquired MR information in integrated MR-PET scanners. Students will have the opportunity to use advanced MR-PET methods to study the delivery, mechanism of action and effects of therapeutic agents in cancer patients.


Bryan Spring, Ph.D.

Assistant Professor, NEU

The ultimate goal of the program is to reduce cancer recurrence and mortality by establishing new approaches for personalized medicine that address tumor heterogeneity, drug-resistance and molecular mechanisms of treatment escape. Advanced-stage cancer patients are presently subjected to a grueling treatment regimen consisting of surgical tumor debulking and high-dose-intensity chemotherapy. These standard approaches frequently hit a wall due to dose-limiting toxicities as well as mechanisms of drug-resistance and treatment escape via cell signaling networks.


Trainee Spotlight


Chris Li

Health Science, '18

The Assessment and Comparison of Ferumoxtran as Contrast Imaging Agent in Patients with Pancreatic Cancers.

Ann Marie Billig

Health Science, '18

miRNA analysis in mouse model of metastatic breast cancer. (Proj 2) The inhibition of PD-L1 on a Pan02 cell line w/ siRNA-nanodrug & gemcitabine treatment

Nicholas LoRocco

Biochemistry, '20

Quantitative Multimodal Imaging of Tumor Response to Radiation


Going on in the lab right now...